Phase 1 Test-retest Evaluation of [18F]MK-6240 PET as an Imaging Marker for Neurofibrillary Tangles in the Brain of Patients With Alzheimer's Disease Compared to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Fluorine-18-MK 6240 (Primary) ; Florbetapir F 18
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Molecular NeuroImaging
- 06 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 06 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 09 Mar 2017 New trial record